Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 45.34
(-0.33%)
CNY 45.34
(-0.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.75 Billion CNY | -30.2% |
| 2022 | 3.94 Billion CNY | 6.7% |
| 2021 | 3.69 Billion CNY | -6.29% |
| 2020 | 3.94 Billion CNY | 50.54% |
| 2019 | 2.61 Billion CNY | 2.16% |
| 2018 | 2.56 Billion CNY | 22.29% |
| 2017 | 2.09 Billion CNY | 44.0% |
| 2016 | 1.45 Billion CNY | 27.81% |
| 2015 | 1.13 Billion CNY | 42.91% |
| 2014 | 796.98 Million CNY | 41.21% |
| 2013 | 564.39 Million CNY | 25.42% |
| 2012 | 450.01 Million CNY | 2.4% |
| 2011 | 439.47 Million CNY | 4.44% |
| 2010 | 420.8 Million CNY | 26.04% |
| 2009 | 333.85 Million CNY | 45.21% |
| 2008 | 229.91 Million CNY | -39.58% |
| 2007 | 380.5 Million CNY | 89.24% |
| 2006 | 201.07 Million CNY | 13.53% |
| 2005 | 177.1 Million CNY | -31.18% |
| 2004 | 257.32 Million CNY | -52.99% |
| 2003 | 547.33 Million CNY | 38.71% |
| 2002 | 394.6 Million CNY | 9.3% |
| 2001 | 361.03 Million CNY | 15.09% |
| 2000 | 313.7 Million CNY | 4.16% |
| 1999 | 301.17 Million CNY | 34.45% |
| 1998 | 223.99 Million CNY | 15.83% |
| 1997 | 193.37 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.9 Billion CNY | 41.77% |
| 2024 Q2 | 4.95 Billion CNY | 26.94% |
| 2024 Q3 | 4 Billion CNY | -19.09% |
| 2023 Q4 | 2.75 Billion CNY | 3.25% |
| 2023 Q1 | 2.81 Billion CNY | -28.47% |
| 2023 Q2 | 2.52 Billion CNY | -10.44% |
| 2023 FY | 2.75 Billion CNY | -30.2% |
| 2023 Q3 | 2.66 Billion CNY | 5.52% |
| 2022 Q1 | 3.03 Billion CNY | -17.86% |
| 2022 Q3 | 2.86 Billion CNY | -30.3% |
| 2022 FY | 3.94 Billion CNY | 6.7% |
| 2022 Q4 | 3.94 Billion CNY | 37.57% |
| 2022 Q2 | 4.11 Billion CNY | 35.46% |
| 2021 Q3 | 4.13 Billion CNY | 14.03% |
| 2021 Q4 | 3.69 Billion CNY | -10.57% |
| 2021 Q1 | 3.68 Billion CNY | -6.53% |
| 2021 FY | 3.69 Billion CNY | -6.29% |
| 2021 Q2 | 3.62 Billion CNY | -1.69% |
| 2020 Q2 | 2.96 Billion CNY | 2.29% |
| 2020 Q1 | 2.89 Billion CNY | 10.67% |
| 2020 Q3 | 4.13 Billion CNY | 39.31% |
| 2020 Q4 | 3.94 Billion CNY | -4.54% |
| 2020 FY | 3.94 Billion CNY | 50.54% |
| 2019 Q3 | 2.69 Billion CNY | 4.84% |
| 2019 Q2 | 2.57 Billion CNY | -4.2% |
| 2019 FY | 2.61 Billion CNY | 2.16% |
| 2019 Q1 | 2.68 Billion CNY | 4.77% |
| 2019 Q4 | 2.61 Billion CNY | -2.92% |
| 2018 Q1 | 1.9 Billion CNY | -9.01% |
| 2018 Q2 | 2.38 Billion CNY | 24.94% |
| 2018 Q3 | 2.15 Billion CNY | -9.59% |
| 2018 FY | 2.56 Billion CNY | 22.29% |
| 2018 Q4 | 2.56 Billion CNY | 18.98% |
| 2017 Q1 | 1.61 Billion CNY | 11.12% |
| 2017 FY | 2.09 Billion CNY | 44.0% |
| 2017 Q4 | 2.09 Billion CNY | 35.14% |
| 2017 Q3 | 1.55 Billion CNY | -0.28% |
| 2017 Q2 | 1.55 Billion CNY | -3.83% |
| 2016 Q2 | 1.23 Billion CNY | 7.1% |
| 2016 FY | 1.45 Billion CNY | 27.81% |
| 2016 Q3 | 1.45 Billion CNY | 17.58% |
| 2016 Q1 | 1.15 Billion CNY | 1.16% |
| 2016 Q4 | 1.45 Billion CNY | 0.33% |
| 2015 FY | 1.13 Billion CNY | 42.91% |
| 2015 Q4 | 1.13 Billion CNY | 6.05% |
| 2015 Q1 | 897.96 Million CNY | 12.67% |
| 2015 Q2 | 953.05 Million CNY | 6.13% |
| 2015 Q3 | 1.07 Billion CNY | 12.69% |
| 2014 Q1 | 627.84 Million CNY | 11.24% |
| 2014 Q3 | 783.57 Million CNY | 9.05% |
| 2014 Q2 | 718.56 Million CNY | 14.45% |
| 2014 Q4 | 796.98 Million CNY | 1.71% |
| 2014 FY | 796.98 Million CNY | 41.21% |
| 2013 Q1 | 569.13 Million CNY | 26.47% |
| 2013 Q2 | 574.35 Million CNY | 0.92% |
| 2013 Q3 | 693.81 Million CNY | 20.8% |
| 2013 Q4 | 564.39 Million CNY | -18.65% |
| 2013 FY | 564.39 Million CNY | 25.42% |
| 2012 Q2 | 478.47 Million CNY | -20.53% |
| 2012 Q1 | 602.08 Million CNY | 37.0% |
| 2012 Q4 | 450.01 Million CNY | -4.79% |
| 2012 FY | 450.01 Million CNY | 2.4% |
| 2012 Q3 | 472.67 Million CNY | -1.21% |
| 2011 FY | 439.47 Million CNY | 4.44% |
| 2011 Q4 | 439.47 Million CNY | -24.23% |
| 2011 Q3 | 579.98 Million CNY | 17.79% |
| 2011 Q2 | 492.37 Million CNY | 13.5% |
| 2011 Q1 | 433.79 Million CNY | 3.09% |
| 2010 Q2 | 444.98 Million CNY | -8.99% |
| 2010 Q4 | 420.8 Million CNY | 24.52% |
| 2010 FY | 420.8 Million CNY | 26.04% |
| 2010 Q3 | 337.93 Million CNY | -24.06% |
| 2010 Q1 | 488.92 Million CNY | 46.45% |
| 2009 FY | 333.85 Million CNY | 45.21% |
| 2009 Q3 | 274.4 Million CNY | 10.33% |
| 2009 Q1 | 270.5 Million CNY | 17.65% |
| 2009 Q2 | 248.7 Million CNY | -8.06% |
| 2009 Q4 | 333.85 Million CNY | 21.67% |
| 2008 Q3 | 270.21 Million CNY | 1.49% |
| 2008 FY | 229.91 Million CNY | -39.58% |
| 2008 Q1 | 283.87 Million CNY | -25.4% |
| 2008 Q2 | 266.24 Million CNY | -6.21% |
| 2008 Q4 | 229.91 Million CNY | -14.91% |
| 2007 Q4 | 380.5 Million CNY | 10.97% |
| 2007 Q3 | 342.88 Million CNY | 23.78% |
| 2007 Q2 | 277.01 Million CNY | -6.11% |
| 2007 Q1 | 295.05 Million CNY | 46.74% |
| 2007 FY | 380.5 Million CNY | 89.24% |
| 2006 Q1 | 197.67 Million CNY | 11.62% |
| 2006 Q2 | 220.51 Million CNY | 11.55% |
| 2006 Q3 | 202.47 Million CNY | -8.18% |
| 2006 FY | 201.07 Million CNY | 13.53% |
| 2006 Q4 | 201.07 Million CNY | -0.69% |
| 2005 Q1 | 275.36 Million CNY | 7.01% |
| 2005 FY | 177.1 Million CNY | -31.18% |
| 2005 Q2 | 192.71 Million CNY | -30.01% |
| 2005 Q3 | 172.16 Million CNY | -10.67% |
| 2005 Q4 | 177.1 Million CNY | 2.87% |
| 2004 Q1 | 392.74 Million CNY | -28.24% |
| 2004 Q3 | 194.18 Million CNY | -39.68% |
| 2004 Q4 | 257.32 Million CNY | 32.52% |
| 2004 Q2 | 321.94 Million CNY | -18.03% |
| 2004 FY | 257.32 Million CNY | -52.99% |
| 2003 Q4 | 547.33 Million CNY | -0.6% |
| 2003 Q1 | 458.28 Million CNY | 16.14% |
| 2003 Q3 | 550.62 Million CNY | -1.88% |
| 2003 Q2 | 561.17 Million CNY | 22.45% |
| 2003 FY | 547.33 Million CNY | 38.71% |
| 2002 Q2 | 365.36 Million CNY | -8.24% |
| 2002 Q1 | 398.17 Million CNY | 10.29% |
| 2002 FY | 394.6 Million CNY | 9.3% |
| 2002 Q4 | 394.6 Million CNY | 13.5% |
| 2002 Q3 | 347.65 Million CNY | -4.85% |
| 2001 FY | 361.03 Million CNY | 15.09% |
| 2001 Q2 | 329.42 Million CNY | 0.0% |
| 2001 Q4 | 361.03 Million CNY | 0.0% |
| 2000 Q4 | 313.7 Million CNY | 0.0% |
| 2000 FY | 313.7 Million CNY | 4.16% |
| 1999 FY | 301.17 Million CNY | 34.45% |
| 1998 FY | 223.99 Million CNY | 15.83% |
| 1997 FY | 193.37 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.14 Billion CNY | 12.438% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.88 Billion CNY | 29.244% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 887.5 Million CNY | -210.016% |
| Aurora Optoelectronics Co.,Ltd. | 1.09 Billion CNY | -150.173% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 290.34 Million CNY | -847.654% |
| NanJing Pharmaceutical Company Limited | 20.95 Billion CNY | 86.872% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.12 Billion CNY | -145.542% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 527.57 Million CNY | -421.523% |